Special Warning : אזהרת שימוש

4.4    Special warnings and precautions for use
Hypersensitivity
Immediate hypersensitivity reactions may occur following the use of Aerovent, such as rare cases of rash, urticaria, angioedema, oropharyngeal oedema, bronchospasm and anaphylaxis.

Paradoxical bronchospasm
As with other inhaled medications, Aerovent may cause paradoxical bronchospasm, which may be life-threatening. If paradoxical bronchospasm occurs, Aerovent must be discontinued immediately and replaced with an alternative therapy.

Special populations:

Ocular complications
Care must be taken not to allow the solution or mist to enter into the eyes.
Aerovent should be used with caution in patients with a predisposition for narrow-angle glaucoma.
If the product accidentally comes into contact with the eyes during use, mild, reversible ocular complications may occur. There is a risk of an acute glaucoma attack, particularly in patients with narrow-angle glaucoma; the characteristic symptoms are eye pain, blurred vision, visual halos or coloured images, red eyes and corneal oedema.
If mydriasis and mild accommodation disorders occur, treatment with miotic drops may be given. In the event of severe ocular complications, an ophthalmologist should also be consulted.

In these patients, a mouthpiece rather than a face mask should ideally be used for inhalation in order to prevent the product from getting into the eyes.

Effect on the kidneys and urinary tract
Aerovent                                                              Proposed prescribing information Boehringer Ingelheim                                                       January 2022- Minor Update 

In patients with micturition disorders (such as in prostatic hypertrophy or bladder neck obstruction), the benefit of treatment with ipratropium bromide must be carefully weighed against the potential risk of aggravating urinary retention.

Gastrointestinal motility disorders
Patients with cystic fibrosis are more likely to develop gastrointestinal motility disorders.

Local effects
This product contains the preservative benzalkonium chloride (100 µg/mL). Benzalkonium chloride can cause bronchospasms, especially in patients with asthma.

Effects on Driving